Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zealand Pharma A/S ADR (ZEAL)

Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 818,603
  • Shares Outstanding, K 46,538
  • Annual Sales, $ 46,550 K
  • Annual Income, $ -161,990 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.45
  • Price/Sales 17.38
  • Price/Cash Flow N/A
  • Price/Book 7.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.76
  • Most Recent Earnings $-1.40 on 08/11/22
  • Next Earnings Date 11/10/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.83
  • Number of Estimates 1
  • High Estimate -0.83
  • Low Estimate -0.83
  • Prior Year -0.73
  • Growth Rate Est. (year over year) -13.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.51 +6.54%
on 09/19/22
20.03 -12.18%
on 09/09/22
+0.42 (+2.45%)
since 08/29/22
3-Month
12.82 +37.21%
on 07/01/22
20.49 -14.15%
on 08/25/22
+4.36 (+32.96%)
since 06/29/22
52-Week
9.93 +77.14%
on 05/16/22
32.94 -46.60%
on 11/01/21
-11.97 (-40.49%)
since 09/29/21

Most Recent Stories

More News
Zealand Pharma Announces Financial Results for the First Half of 2022

Company Announcement No. 34 / 2022 Interim report for H1 2022 Zealand Pharma Announces Financial Results for the First Half of 2022 Copenhagen, DK...

ZEAL : 17.59 (+1.21%)
Updated notice to holders of ADSs regarding termination of Deposit Agreement

NOTICE TO HOLDERS OF AMERICAN DEPOSITARY SHARES (“ADSs”)EVIDENCED BYAMERICAN DEPOSITARY RECEIPTS (“ADRs”)REPRESENTING DEPOSITED ORDINARY SHARES...

ZEAL : 17.59 (+1.21%)
Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market

Company announcement – No. 32 / 2022 Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select...

ZEAL : 17.59 (+1.21%)
Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022

Company announcement – No. 31 / 2022 Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for...

ZEAL : 17.59 (+1.21%)
Total number of shares and voting rights in Zealand Pharma at June 30, 2022

Company announcement – No. 30 / 2022 Total number of shares and voting rights in Zealand Pharma at June 30, 2022 Copenhagen, DK and Boston, MA, June 30,...

ZEAL : 17.59 (+1.21%)
Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design

Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company...

ZEAL : 17.59 (+1.21%)
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

Company announcement – No. 29 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and...

ZEAL : 17.59 (+1.21%)
Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

Company announcement – No. 28 / 2022 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 Copenhagen, DK and Boston, MA, 10 June...

ZEAL : 17.59 (+1.21%)
Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity

COMPANY ANNOUNCEMENT – NO. 27/ 2022 Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association...

ZEAL : 17.59 (+1.21%)
Zealand Pharma completes registration of capital increase

Company announcement – No. 26 / 2022 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR...

ZEAL : 17.59 (+1.21%)

Business Summary

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.

See More

Key Turning Points

3rd Resistance Point 18.55
2nd Resistance Point 18.31
1st Resistance Point 17.95
Last Price 17.59
1st Support Level 17.35
2nd Support Level 17.11
3rd Support Level 16.75

See More

52-Week High 32.94
Fibonacci 61.8% 24.15
Fibonacci 50% 21.43
Fibonacci 38.2% 18.72
Last Price 17.59
52-Week Low 9.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar